LTS12674

Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial


Investigational Site Number 840017
Voorhees, NJ 08043

Investigational Site Number 840010
Albany, NY 12206

Investigational Site Number 840030
Boston, MA 02115

Investigational Site Number 840005
Norfolk, VA 23502

Investigational Site Number 840021
Pittsburgh, PA 15213

Investigational Site Number 380002
Genova 16132

Investigational Site Number 840043
Cleveland, OH 44106

Investigational Site Number 840001
Detroit, MI 48201

Investigational Site Number 840015
Charlotte, NC 28204

Investigational Site Number 840012
Indianapolis, IN 46227

Investigational Site Number 840055
Tucker, GA 30084

Investigational Site Number 840039
Maywood, IL 60153

Investigational Site Number 840027
Jacksonville, FL 32256

Investigational Site Number 840013
Birmingham, AL 35205

Investigational Site Number 840004
St. Louis, MO 63141

Investigational Site Number 840028
Memphis, TN 38120

Investigational Site Number 840006
Minneapolis, MN 55407

Investigational Site Number 840002
Jackson, MS 39202

Investigational Site Number 840025
Sioux City, IA 51105

Investigational Site Number 840019
Plano, TX 75075

Investigational Site Number 840007
Austin, TX 78731

Investigational Site Number 840008
Denver, CO 80218

Investigational Site Number 840003
El Paso, TX 79915

Investigational Site Number 840022
Las Vegas, NV 89169

Investigational Site Number 840009
Vancouver, WA 98684

Investigational Site Number 840033
Santa Maria, CA 93454

Kaiser Permanente Oncology Clinical Trials, Northern California
KPOCT Administrative Center, 975 Sereno Drive
Vallejo, CA 94589
(877) 642-4691

Investigational Site Number 840046
Vallejo, CA 94589

Investigational Site Number 056002
Leuven 3000

Investigational Site Number 724001
Valencia 46010